Highlights BioHarvest Sciences Inc. Canadian Securities Exchange

Equities

BHSC

CA13767B1013

Delayed Canadian Securities Exchange Other stock markets 10:24:58 2021-10-05 am EDT			5-day change	1st Jan Change
0.35 ^CAD	+6.06%		-2.94%	+46.67%

Jun. 28	BioHarvest Sciences Raises US$4.3 Million in First Tranche of Financing, Reports Debt Notes Conversion	MT
Jun. 21	BioHarvest Sciences Announces US$5 Million Private-Placement Financing, Conversion of Debt Notes	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

BioHarvest Sciences Raises US$4.3 Million in First Tranche of Financing, Reports Debt Notes Conversion	Jun. 28	MT
BioHarvest Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 30	CI
BioHarvest Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 30	CI
BioHarvest Sciences Inc. Provides Revenue Guidance for the First Quarter and Second Quarter of 2024	Apr. 30	CI
BioHarvest Sciences Inc. Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity	Apr. 16	CI
BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules	Feb. 26	MT
BioHarvest Sciences Inc. Announces Launch of New Contract Development and Manufacturing Organization Business Unit	Feb. 26	CI
BioHarvest Sciences Inc. Signs First Contracts with Two Industrial Customers to Develop Complex Molecules Via Its Newly Launched Botanical Synthesis CDMO Business Unit	Feb. 26	CI
Bioharvest Sciences Inc. Announces Major Product Launch of Vinia-Based Functional Coffee Products	Dec. 13	CI
BioHarvest Sciences Inc. Provides Revenue Guidance for the Fourth Quarter 2023	Nov. 29	CI
Bioharvest Sciences Inc. Revises Revenue Guidance for the Year 2023	Nov. 29	CI
BioHarvest Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 27	CI
BioHarvest Sciences Inc. Receives Canadian Product License from Health Canada's Natural and Non-Prescription Health Products Directorate	23-10-10	CI
BioHarvest Sciences Inc. Provides Revenue Guidance for the Third Quarter of 2023	23-08-29	CI
BioHarvest Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-28	CI
Bioharvest Sciences Inc. Reiterated Sales Guidance for the year 2023	23-05-31	CI
BioHarvest Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-30	CI
BioHarvest Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-27	CI
BioHarvest Sciences Inc. Announces Clinical Study in Patients with Multiple Sclerosis-Related Optic Neuritis	23-02-14	CI
Bioharvest Sciences Inc. Provides Revenue Guidance for the Year 2022 and 2023	22-12-15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights BioHarvest Sciences Inc. Canadian Securities Exchange

Equities

BHSC

CA13767B1013

Highlights

Filters